Related Experiment Video
Updated: Apr 27, 2026
Focal Laser Ablation of Prostate Cancer: An Office Procedure
Published on: March 30, 2021
Focal laser ablation for localized prostate cancer: principles, clinical trials, and our initial experience
Ted Lee1, Neil Mendhiratta1, Dan Sperling2
1Department of Urology, New York University School of Medicine, New York, NY.
Abstract:
Focal therapy of prostate cancer is an evolving treatment strategy that destroys a predefined region of the prostate gland that harbors clinically significant disease. Although long-term oncologic control has yet to be demonstrated, focal therapy is associated with a marked decrease in treatment-related morbidity. Focal laser ablation is an emerging modality that has several advantages, most notably real-time magnetic resonance imaging (MRI) compatibility. This review presents the principles of laser ablation, the role of multiparametric MRI for delineating the site of significant prostate cancer, a summary of published clinical studies, and our initial experience with 23 patients, criteria for selecting candidates for focal prostate ablation, and speculation regarding future directions.
Insights
Focal laser ablation offers a promising approach to treating prostate cancer by targeting only diseased tissue, potentially reducing side effects. Further research is needed to confirm its long-term effectiveness in oncologic control.
Area of Science:
- Urology
- Oncology
- Medical Technology
Background:
- Focal therapy is an evolving strategy for prostate cancer, aiming to destroy only cancerous tissue.
- It offers a potential reduction in treatment-related morbidity compared to traditional methods.
- Focal laser ablation (FLA) is an emerging technique with real-time MRI compatibility.
Purpose of the Study:
- To review the principles and clinical applications of focal laser ablation for prostate cancer.
- To discuss the role of multiparametric MRI in cancer detection and treatment planning.
- To present initial clinical experience and future directions for FLA.
Main Methods:
- Review of principles of laser ablation and multiparametric MRI.
- Summary of published clinical studies on focal prostate ablation.
- Presentation of initial experience with 23 patients undergoing FLA.
Main Results:
- Focal therapy is associated with decreased treatment-related morbidity.
- Real-time MRI compatibility is a key advantage of FLA.
- Initial patient data and selection criteria for FLA are discussed.
Conclusions:
- Focal laser ablation is a developing treatment for prostate cancer with potential for reduced morbidity.
- Multiparametric MRI is crucial for guiding focal therapy.
- Long-term oncologic outcomes require further investigation.
